You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 19, November 19, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Impact of a clinical guidelines program for breast and colon cancer in a French cancer center

I. Ray-Coquard, T. Philip, M. Lehmann, B. Fervers, F. Farsi and F. Chauvin
Centre Leon Berard, Lyon, France. ray@lyon.fnclcc.fr

CONTEXT: Between 1993 and 1994, the 80 physicians in the French comprehensive cancer center, Leon Berard, developed and implemented a Clinical Practice Guidelines (CPGs) project based on an analysis of the literature and a consensus of intrainstitutional experts. OBJECTIVE: The aims of this project are to assist community-based oncologists in their decision making and to minimize inappropriate variation in practices. A study was designed to assess the impact of CPGs on management of breast and colon cancer. DESIGN: A "before-after" study, using institutional computerized records of patients with breast or colon cancer. SETTING: Records for 100 women with localized breast cancer were randomly selected from those available in 1993 and 1995, and those for all patients newly referred with colon cancer in 1993 and 1995 (77 and 81 patients, respectively). Medical decisions on these records were analyzed to assess their compliance with the CPGs. (A systematic search of the literature was performed to determine the scientific evidence for noncompliant decisions.) RESULTS: Of 375 available medical decisions, 350 were assessable. The compliance rate with CPGs for breast cancer was significantly higher in 1995 compared with 1993, 54% (54/99; 95% confidence interval [CI], 44%-64%) vs 19% (18/95; 95% CI, 11%-27%) (P<.001). The compliance rate for colon cancer was also significantly higher in 1995 than in 1993, 70% (62/88; 95% CI, 60%-80%) vs 50% (34/ 68; 95% CI, 38%-62%) (P=.009). In 1993, 42% (40/95; 95% CI, 32%-52%) of medical decisions for breast cancer and in 1995, 68% (67/99; 95% CI, 59%-77%) conformed with the CPGs or were judged to be based on "scientific evidence." In 1993, 71% (48/68; 95% CI, 60%-81%) of medical decisions for colon cancer, and in 1995 81% (71/88; 95% CI, 73%-89%) conformed with the CPGs or were judged to be based on scientific evidence. CONCLUSIONS: Compliance rates were significantly higher in 1995 for both cancers. The development and implementation of CPGs for cancer management seem to result in significant changes in medical practice, although a causal relationship between changes and CPGs is not demonstrated in this study.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

"What's in the Black Box?"
Kunz
Chest 2006;129:7-10.
FULL TEXT  

Persistence of Medical Change at Implementation of Clinical Guidelines on Medical Practice: A Controlled Study in a Cancer Network
Ray-Coquard et al.
JCO 2005;23:4414-4423.
ABSTRACT | FULL TEXT  

Predictors of high quality clinical practice guidelines: examples in oncology
Fervers et al.
Int J Qual Health Care 2005;17:123-132.
ABSTRACT | FULL TEXT  

International Assessment of the Quality of Clinical Practice Guidelines in Oncology Using the Appraisal of Guidelines and Research and Evaluation Instrument
Burgers et al.
JCO 2004;22:2000-2007.
ABSTRACT | FULL TEXT  

Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas
Ray-Coquard et al.
Ann Oncol 2004;15:307-315.
ABSTRACT | FULL TEXT  

Critical appraisal of the Minimal Clinical Recommendations (MCR) of the European Society for Medical Oncology (ESMO): challenges for a European framework for the development of clinical practice guidelines
Fervers et al.
Ann Oncol 2002;13:1507-1509.
FULL TEXT  

The Impact of Practice Guidelines in the Management of Barrett Esophagus: A National Prospective Cohort Study of Physicians
Cruz-Correa et al.
Arch Intern Med 2001;161:2588-2595.
ABSTRACT | FULL TEXT  

Ensuring Quality Cancer Care by the Use of Clinical Practice Guidelines and Critical Pathways
Smith and Hillner
JCO 2001;19:2886-2897.
ABSTRACT | FULL TEXT  

Economic Impact of Harmonizing Medical Practices: Compliance With Clinical Practice Guidelines in the Follow-Up of Breast Cancer in a French Comprehensive Cancer Center
Mille et al.
JCO 2000;18:1718-1724.
ABSTRACT | FULL TEXT  

Use of Hematopoietic Colony-Stimulating Factors: Comparison of the 1994 and 1997 American Society of Clinical Oncology Surveys Regarding ASCO Clinical Practice Guidelines
Bennett et al.
JCO 1999;17:3676-3681.
ABSTRACT | FULL TEXT  

Proposed Agenda for the Measurement of Quality-of-Care Outcomes in Oncology Practice
Mandelblatt et al.
JCO 1999;17:2614-2614.
ABSTRACT | FULL TEXT  

Guidelines Improve Cancer Screening Rates
JWatch Women's Health 1998;1998:10-10.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.